Regeneron

Regeneron is a biotechnology company that develops medicines to treat various health conditions, including eye diseases, cancer, and inflammatory disorders. It uses advanced genetic and antibody technologies to create targeted therapies, which help the immune system fight diseases more effectively. Regeneron's approach often involves designing medicines that specifically block or modulate certain molecules involved in disease processes, leading to potentially more effective and fewer side effects. The company is known for innovative treatments like those for age-related macular degeneration and COVID-19. Overall, Regeneron aims to improve patient outcomes through cutting-edge scientific research and development.